tiprankstipranks
Advertisement
Advertisement

UPB Stock Latest News

VALIANT Asthma Trial Update: What Upstream Bio’s Phase 2 Milestone Means for Investors
Company AnnouncementsVALIANT Asthma Trial Update: What Upstream Bio’s Phase 2 Milestone Means for Investors
15h ago
UPB
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
PremiumThe Fly
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
16h ago
U
CG
Wix downgraded, TripAdvisor upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Wix downgraded, TripAdvisor upgraded: Wall Street’s top analyst calls
18h ago
TW
AGX
Upstream Bio downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Upstream Bio downgraded to In Line from Outperform at Evercore ISI
21h ago
UPB
Upstream Bio Launches $150 Million At-The-Market Program
PremiumCompany Announcements
Upstream Bio Launches $150 Million At-The-Market Program
1d ago
8K
UPB
Upstream Bio Initiated at Buy: Verekitug’s Quarterly Dosing Strategy Positions It for Potential Best-in-Class Efficacy vs. TSLP Competitors
PremiumRatingsUpstream Bio Initiated at Buy: Verekitug’s Quarterly Dosing Strategy Positions It for Potential Best-in-Class Efficacy vs. TSLP Competitors
2d ago
UPB
Verekitug’s Differentiated Long-Interval Dosing and Late-Stage Pipeline Position It as a Potential Respiratory Blockbuster
Premium
Ratings
Verekitug’s Differentiated Long-Interval Dosing and Late-Stage Pipeline Position It as a Potential Respiratory Blockbuster
2d ago
UPB
Buy Rating Backed by VALIANT Phase 2 Asthma Data and Differentiated, Infrequent-Dosing Profile for Verekitug
Premium
Ratings
Buy Rating Backed by VALIANT Phase 2 Asthma Data and Differentiated, Infrequent-Dosing Profile for Verekitug
2d ago
UPB
Is UPB a Buy, Before Earnings?
PremiumPre-Earnings
Is UPB a Buy, Before Earnings?
12d ago
UPB
Buy Rating on UPB Driven by Robust Verekitug Phase 2 Data and Upcoming Phase 3 Catalysts in CRSwNP and Severe Asthma
PremiumRatings
Buy Rating on UPB Driven by Robust Verekitug Phase 2 Data and Upcoming Phase 3 Catalysts in CRSwNP and Severe Asthma
25d ago
UPB
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
PremiumMarket News
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
25d ago
UPB
VERA
Upstream Bio announces verekitug met the primary endpoint
PremiumThe Fly
Upstream Bio announces verekitug met the primary endpoint
27d ago
UPB
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026?
PremiumMarket NewsXBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026?
1M ago
IBB
UPB
Midday Fly By: January payrolls jump, Ford reports mixed Q4
Premium
The Fly
Midday Fly By: January payrolls jump, Ford reports mixed Q4
1M ago
F
PM
Buy Rating on UPB Driven by Tezspire‑Comparable Efficacy, Convenient Q12W Dosing, and Solid Cash Runway Supporting Verekitug’s Long‑Term Potential
Premium
Ratings
Buy Rating on UPB Driven by Tezspire‑Comparable Efficacy, Convenient Q12W Dosing, and Solid Cash Runway Supporting Verekitug’s Long‑Term Potential
1M ago
UPB
Upstream Bio Reports Positive Phase 2 Verekitug Asthma Results
PremiumCompany Announcements
Upstream Bio Reports Positive Phase 2 Verekitug Asthma Results
1M ago
8K
UPB
Upstream Bio Reports Positive Phase 2 Severe Asthma Data
PremiumCompany Announcements
Upstream Bio Reports Positive Phase 2 Severe Asthma Data
1M ago
8K
UPB
Upstream Bio reports results from Phase 2 VALIANT clinical trial
PremiumThe Fly
Upstream Bio reports results from Phase 2 VALIANT clinical trial
1M ago
UPB
Upstream Bio management to meet virtually with Piper Sandler
PremiumThe Fly
Upstream Bio management to meet virtually with Piper Sandler
2M ago
UPB
Positioning Upstream Bio for Commercial Success: Buy Rating on UPB Driven by Physician Enthusiasm and Long-Acting TSLP Opportunity Ahead of VALINAT Readout
PremiumRatingsPositioning Upstream Bio for Commercial Success: Buy Rating on UPB Driven by Physician Enthusiasm and Long-Acting TSLP Opportunity Ahead of VALINAT Readout
2M ago
UPB
Upstream Bio initiated with an Outperform at Mizuho
Premium
The Fly
Upstream Bio initiated with an Outperform at Mizuho
3M ago
UPB
Upstream Bio initiated with an Outperform at LifeSci Capital
Premium
The Fly
Upstream Bio initiated with an Outperform at LifeSci Capital
4M ago
UPB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >